Effect of pramipexole on cutaneous-silent-period parameters in patients with restless legs syndrome

Clinical Neurophysiology

Volumn 123, Issue 1, 2012, Pages 154-159

  Öz, Oĝuzhan ^a   Erdoĝan, Çaĝdaş ^a   Yücel, Mehmet ^a   Akgün, Hakan ^a   Kütükçü, Yaşar ^a   Gökçil, Zeki ^a   Odabaşi, Zeki ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Cutaneous silent period; Pramipexole; Restless legs syndrome

Indexed keywords

PRAMIPEXOLE;

ADULT; AGED; ARM; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CUTANEOUS SILENT PERIOD; FEMALE; HUMAN; LEG; MALE; NERVOUS SYSTEM PARAMETERS; NEUROPATHY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RESTLESS LEGS SYNDROME;

ADULT; AGED; AGED, 80 AND OVER; BENZOTHIAZOLES; DOPAMINE AGONISTS; FEMALE; HUMANS; LOWER EXTREMITY; MALE; MIDDLE AGED; RESTLESS LEGS SYNDROME; TREATMENT OUTCOME; UPPER EXTREMITY;

EID: 84655161953     PISSN: 13882457     EISSN: 18728952     Source Type: Journal    
DOI: 10.1016/j.clinph.2011.05.027     Document Type: Article

References (33)

1. Akpi{dotless}nar Ş. The primary restless legs syndrome pathogenesis depends on the dysfunction of EEG an activity. Med Hypotheses 2003, 60(2):190-198.
2. Auger C., Montplaisir J., Duquette P. Increased frequency of restless legs syndrome in a French-Canadian population with multiple sclerosis. Neurology 2005, 65:1652-1653.
3. Bara-Jimenez W., Aksu M., Graham B., Sato S., Hallett M. Periodic limb movements in sleep: state-dependent excitability of the spinal flexor reflex. Neurology 2000, 54(8):1609-1616.
4. Entezari-Taher M., Singleton J.R., Jones C.R., Meekins G., Petajan J.H., Smith A.G. Changes in excitability of motor cortical circuitry in primary restless legs syndrome. Neurology 1999, 53(6):1201-1205.
5. Floeter M.K. Cutaneous silent periods. Muscle Nerve 2003, 28:391-401.
6. Gemignani F., Brindani F., Negrotti A., Vitetta F., Alfieri S., Marbini A. Restless legs syndrome and polyneuropathy. Mov Disord 2006, 21:1254-1257.
7. Gigli G.L., Adorati M., Dolso P., Piani A., Valente M., Brotini S., et al. Restless legs syndrome in end-stage renal disease. Sleep Med 2004, 5:309-315.
8. Gorsler A., Liepert J. Influence of cabergoline on motor excitability in patients with restless legs syndrome. J Clin Neurophysiol 2007, 24(6):456-460.
9. Han J.K., Oh K., Kim B.J., Koh S.B., Kim J.Y., Park K.W., et al. Cutaneous silent period in patients with restless legs syndrome. Clin Neurophysiol 2007, 11:1705-1710.
10. Higgins D.C., Lieberman J.S. The muscle silent period: variability in normal man. Electroencephalogr Clin Neurophysiol 1968, 24:176-182.
11. Iannaccone S., Zucconi M., Marchettini P., Ferini-Strambi L., Nemni R., Quattrini A., et al. Evidence of peripheral axonal neuropathy in primary restless legs syndrome. Mov Disord 1995, 10:2-9.
12. Isak B., Uluc K., Salcini C., Agan K., Tanridag T., Us O. A neurophysiological approach to the complex organization of the spine: F-wave duration and the cutaneous silent period in restless legs syndrome. Clin Neurophysiol 2011, 122(2):383-390.
13. Kranz H., Adorjani C., Baumgartner G. The effect of nociceptive cutaneous stimuli in human motoneurons. Brain 1973, 96:571-590.
14. Kütükçü Y., Doĝruer E., Yetkin S., özgen F., Vural O., Aydin H. Evaluation of periodic leg movements and associated transcranial magnetic stimulation parameters in restless legs syndrome. Muscle Nerve 2006, 33:133-137.
15. Leis A.A., Ross M.A., Emori T., Matsue Y., Saito T. The silent period produced by electrical stimulation of mixed peripheral nerves. Muscle Nerve 1991, 14:1202-1208.
16. Leis A.A., Stetkárová I., Beric A., Stokic D.S. Spinal motor neuron excitability during the cutaneous silent period. Muscle Nerve 1995, 18(12):1464-1470.
17. Manconi M., Govoni V., De Vito A., Economou N.T., Cesnik E., Casetta I., et al. Restless legs syndrome and pregnancy. Neurology 2004, 63:1065-1069.
18. Montplaisir J., Godbout R., Boghen D., DeChamplain J., Young S.N., Lapierre G. Familial restless legs with periodic movements in sleep: electrophysiologic, biochemical, and pharmacologic study. Neurology 1985, 35:130-134.
19. Nardone R., Ausserer H., Bratti A., Covi M., Lochner P., Marth R., et al. Cabergoline reverses cortical excitability in patients with restless legs syndrome. Acta Neurol Scand 2006, 114(4):244-249.
20. Onal M.R., Ulas U.H., Oz O., Bek V.S., Yucel M., Taslipinar A., et al. Cutaneous silent period changes in Type 2 diabetes mellitus patients with small fiber neuropathy. Clin Neurophysiol 2010, 121(5):714-718.
21. Ondo W.G., Vuong K.D., Wang Q. Restless legs syndrome in monozygotic twins: clinical correlates. Neurology 2000, 55:1404-1406.
22. Polydefkis M., Allen R.P., Hauer P., Earley C.J., Griffin J.W., McArthur J.C. Subclinical sensory neuropathy in late-onset restless legs syndrome. Neurology 2000, 55:1115-1121.
23. Quatrale R., Manconi M., Gastaldo E., Eleopra R., Tugnoli V., Tola M.R., et al. Neurophysiological study of corticomotor pathways in restless legs syndrome. Clin Neurophysiol 2003, 114(9):1638-1645.
24. Rijsman R.M., Stam C.J., de Weerd A.W. Abnormal H-reflexes in periodic limb movement disorder; impact on understanding the pathophysiology of the disorder. Clin Neurophysiol 2005, 116(1):204-210.
25. Rizzo V., Aricò I., Mastroeni C., Morgante F., Liotta G., Girlanda P., et al. Quartarone A. Dopamine agonists restore cortical plasticity in patients with idiopathic restless legs syndrome. Mov Disord 2009, 24(5):710-715.
26. Scalise A., Pittaro-Cadore I., Golob E.J., Gigli G.L. Absence of postexercise and delayed facilitation of motor cortex excitability in restless legs syndrome: evidence of altered cortical plasticity?. Sleep 2006, 29(6):770-775.
27. Scalise A., Pittaro-Cadore I., Janes F., Marinig R., Gigli G.L. Changes in cortical excitability after dopaminergic treatment in restless legs syndrome. Sleep Med 2010, 11(1):75-81.
28. Serrao M., Parisi L., Pierelli F., Rossi P. Cutaneous afferents mediating the cutaneous silent period in the upper limbs: evidences for a role of low-threshold sensory fibres. Clin Neurophysiol 2001, 112:2007-2014.
29. Tergau F., Wischer S., Paulus W. Motor system excitability in patients with restless legs syndrome. Neurology 1999, 52(5):1060-1063.
30. Tyvaert L., Houdayer E., Devanne H., Bourriez J.L., Derambure P., Monaca C. Cortical involvement in the sensory and motor symptoms of primary restless legs syndrome. Sleep Med 2009, 10(10):1090-1096.
31. Tyvaert L., Laureau E., Hurtevent J.P., Hurtevent J.F., Derambure P., Monaca C. A-delta and C-fibres function in primary restless legs syndrome. Neurophysiol Clin 2009, 39(6):267-274.
32. Walters A.S. Toward a better definition of the restless legs syndrome. The International Restless Legs Syndrome Study Group. Mov Disord 1995, 10:634-642.
33. Winkelmann J., Wetter T.C., Collado-Seidel V., Gasser T., Dichgans M., Yassouridis A., et al. Clinical characteristics and frequency of the hereditary restless legs syndrome in a population of 300 patients. Sleep 2000, 23(5):597-602.